Government Supported Benefits

Faculty Disclosure

As an accredited provider of continuing medical education, it is the policy of the University of Utah to ensure balance, independence, objectivity, and scientific rigor in all of its educational programs. In accordance with this policy, faculty must disclose to the participants any significant relationships with the commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this continuing pharmaceutical education program. The intent of this disclosure is not to prevent a person with a significant financial or other relationship from participating in the planning or review of programs, but rather to provide the intended audience with information on which they can make their own judgments. It remains for the audience to determine whether the interests or relationships of planning committee members, reviewers, or cosponsors may influence the presentation with regard to exposition or conclusion.

FIRST NAME	LAST NAME	COMMERCIAL INTEREST	WHAT WAS RECEIVED?	FOR WHAT ROLE?
Charles	Argoff	ENDO	Honorarium/Consulting Fee	Speaker/Consultant
		GSK	Grant	Research
		Cephalon	Grant/Consulting Fee	Research/Consultant
		Pricara	Honorarium/Consulting Fee	Speaker/Consultant
		Lilly	Honorarium/Consulting Fee	Speaker/Consultant
		King Pharmaceutical	Honorarium	Speaker
		Pfizer, Inc	Honorarium/Consulting Fee	Speaker/Consultant

Dale	Christensen	Northwest Pharmacy Services	Consultant Fee
		Par 3 Communications	Consultant Fee
		WorldDoc Inc	Consultant Fee
		University of North Carolina	Salary

Juliette	Cubanski	NONE

Michael	Doonan	NONE

Jon	Glaudemans	Care Core National	Stipends	Board Membership

Jeff	Guo	NONE

Julie	Kreyenbuhl	NONE

Arthur G.	Lipman	Merck and Co.	Consultant Fee	Speakers bureau
		Pfizer, Inc	Consultant Fee	Speakers bureau
		Bioline, AlPharma	Consultant Fee	n/a
		Medgenex Progenics Pharmaceuticals	Research Funding	n/a
		Wyeth Ortho McNeil, Purdue Pharmaceuticals	Consultant Fee	Speakers bureau

Anita	Murcko	NONE

FIRST NAME	LAST NAME	COMMERCIAL INTEREST	WHAT WAS RECEIVED?	FOR WHAT ROLE?
Jennifer	Polinski	Depuy Orthopedics, Johnson & Johnson	Salary	Employee
		Depuy Orthopedics, Johnson & Johnson	Stock < $8000.00 for J & J	Employee Benefit

Theresa	Shireman	NONE

Lynn R.	Webster	Cephalon	Consultant Fee	Honorarium
		PTI	Consultant Fee	Honorarium
		Elan	Consultant Fee	Honorarium / Research
		King Pharmaceutical	Consultant Fee	Honorarium
		Advanced Bionics	Research Funding
		Torreypines	Research Funding
		Xenoport	Research Funding
		Takeda	Research Funding
		Jazz	Research Funding
		Zars	Research Funding
		Forest	Research Funding
		Merck	Research Funding
		Purdue	Research Funding
		Durect	Research Funding
		Mallinckrodt	Research Funding
		GSK	Research Funding
		Neurogesx	Research Funding
		Predix	Research Funding
		Elite	Research Funding

Jennifer Tija, MD, MSCE, is Assistant Professor of Medicine at the University of Massachusetts Medical School. Dr. Tija has indicated she has nothing to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. University of Utah College of Pharmacy do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the University of Utah College of Pharmacy. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

The entire faculty for this program has reported that they will not discuss unapproved drug or device uses.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Home